PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 173.00
-6.00 (-3.35%)
May 12, 2026, 3:30 PM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 6.39 billion as of May 12, 2026. Its market cap has decreased by -23.67% in one year.
Market Cap
6.39B
Enterprise Value
3.57B
Revenue
684.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
173.00
Market Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 6.39B, a decrease of -64.16%. That is a compound annual growth rate of -42.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 6.62B | 14.89% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.71B |
| Carna Biosciences | 7.64B |
| BrightPath Biotherapeutics | 7.57B |
| Kohjin Bio | 7.57B |
| StemCell Institute | 7.56B |
| ADR120S | 7.31B |
| CellSource | 7.18B |
| Chiome Bioscience | 7.02B |